Interventional cardiology
SPIRIT IV A Prospective, Randomized Trial Comparing an Everolimus-Eluting Stent and a Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease.
Slide 1 PERSEUS Primary Endpoint Dean Kereiakes ACC/i2 Late Breaking Trial Monday, March 15, 2010, 11:06 am TAXUS PERSEUS A Novel Platinum Chromium, Thin-Strut.
The language of CTO interventions – what it all means Dr Angela Hoye Senior Lecturer in Cardiology Hull & East Yorkshire Hospitals.
©2012 Abbott. All rights reserved. 6-EH-4-2567-01 09/2012 REV A Egypt in the 4 th Revolution: ABSORB real life practice Hazem Khamis, MD, FACC October.
Manejo de la antiagregación ajustada a las pruebas de reactividad plaquetaria. Experiencia, Resultados y futuro de un programa nacional. - Dr. Daniel Aradi
MR Terms And Implants
Endeavor IV-A Randomized Comparison of a Zotarolimus-Eluting Stent Endeavor IV-A Randomized Comparison of a Zotarolimus-Eluting Stent
Dornan Engineering Company Brochure
Closure devices
I.V. Enoxaparin or Unfractionated Heparin in Primary PCI: Acute and Long-term results G. M ONTALESCOT, DISCLOSURE : Research Grants to the Institution.
PubMed was searched for randomized clinical trials published between 2007 and 2012 in the New England Journal of Medicine (NEJM) Trials were included if.
